Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-26-064657

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Polverino Anthony J. Director 2026-02-26 Grant or award · Stock Option (Right to Buy) +150,000 $0.70 $105,000 150,000 D: show line 1 in the form
Loading xslF345X06/tm267728-5_4seq1.xml…